Literature DB >> 16182441

Comparative genomic hybridization and BUB1B mutation analyses in childhood cancers associated with mosaic variegated aneuploidy syndrome.

Sandra Hanks1, Kim Coleman, Brenda Summersgill, Boo Messahel, Dan Williamson, Kathryn Pritchard-Jones, Jon Strefford, John Swansbury, Alberto Plaja, Janet Shipley, Nazneen Rahman.   

Abstract

We previously demonstrated that constitutional BUB1B mutations cause mosaic variegated aneuploidy, a condition characterized by constitutional aneuploidies and childhood cancer predisposition. To further investigate the role of BUB1B in cancer predisposition we performed comparative genomic hybridization analysis in an embryonal rhabdomyosarcoma from an MVA case with biallelic BUB1B mutations, revealing aneuploidies typical of sporadic E-RMS, with gain of chromosomes 3, 8, 13 and loss of chromosomes 9, 14, X. To investigate whether somatic BUB1B mutations occur in sporadic childhood cancers we screened 30 Wilms tumours, 10 acute lymphoblastic leukemias, nine rhabdomyosarcomas and 11 rhabdomyosarcoma cell lines for BUB1B mutations. We identified seven exonic and six intronic variants. Six of the exonic variants were synonymous and one resulted in a non-synonymous conservative missense alteration that was also present in a control. These data suggest that the genetic progression in rhabdomyosarcoma from MVA and non-MVA cases may be similar, but that somatic BUB1B mutations are unlikely to be common in sporadic childhood cancers known to be associated with MVA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16182441     DOI: 10.1016/j.canlet.2005.08.006

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  17 in total

Review 1.  New frontiers: discovering cilia-independent functions of cilia proteins.

Authors:  Anastassiia Vertii; Alison Bright; Benedicte Delaval; Heidi Hehnly; Stephen Doxsey
Journal:  EMBO Rep       Date:  2015-09-09       Impact factor: 8.807

2.  Laryngeal embryonal rhabdomyosarcoma in an adult - a case presentation in the eyes of geneticists and clinicians.

Authors:  Wojciech Kukwa; Piotr Wojtowicz; Beata Jagielska; Grzegorz Sobczyk; Andrzej Kukwa; Anna M Czarnecka
Journal:  BMC Cancer       Date:  2011-05-12       Impact factor: 4.430

Review 3.  Constitutional aneuploidy and cancer predisposition.

Authors:  Ithamar Ganmore; Gil Smooha; Shai Izraeli
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

4.  Spindle proteins are differentially expressed in the various histological subtypes of testicular germ cell tumors.

Authors:  Espen Burum-Auensen; Rolf I Skotheim; Aasa R Schjølberg; Jo Røislien; Ragnhild A Lothe; Ole Petter F Clausen
Journal:  J Carcinog       Date:  2010-03-04

Review 5.  Clinical relevance of molecular genetics to paediatric sarcomas.

Authors:  Olga Slater; Janet Shipley
Journal:  J Clin Pathol       Date:  2007-04-27       Impact factor: 3.411

Review 6.  Aneuploidy in health, disease, and aging.

Authors:  Robin M Ricke; Jan M van Deursen
Journal:  J Cell Biol       Date:  2013-04-01       Impact factor: 10.539

Review 7.  BUB1 and BUBR1: multifaceted kinases of the cell cycle.

Authors:  Victor M Bolanos-Garcia; Tom L Blundell
Journal:  Trends Biochem Sci       Date:  2010-10-15       Impact factor: 13.807

8.  Variations in dysfunction of sister chromatid cohesion in esco2 mutant zebrafish reflect the phenotypic diversity of Roberts syndrome.

Authors:  Stefanie M Percival; Holly R Thomas; Adam Amsterdam; Andrew J Carroll; Jacqueline A Lees; H Joseph Yost; John M Parant
Journal:  Dis Model Mech       Date:  2015-06-04       Impact factor: 5.758

Review 9.  Rhabdomyosarcomas: an overview on the experimental animal models.

Authors:  Alessandra Zanola; Stefania Rossi; Fiorella Faggi; Eugenio Monti; Alessandro Fanzani
Journal:  J Cell Mol Med       Date:  2012-07       Impact factor: 5.310

10.  Reduced life- and healthspan in mice carrying a mono-allelic BubR1 MVA mutation.

Authors:  Tobias Wijshake; Liviu A Malureanu; Darren J Baker; Karthik B Jeganathan; Bart van de Sluis; Jan M van Deursen
Journal:  PLoS Genet       Date:  2012-12-27       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.